Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIMDAMAL II
NCT03967054Phase 3Completed
- Start
- Jul 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of CHILD-IVITAB in malaria. Started Jul 2019; status: completed.
02
Drugs
CHILD-IVITAB
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03967054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03967054.